Home / Health / US HHS Reviews Testosterone Therapy Safety
US HHS Reviews Testosterone Therapy Safety
20 Jun
Summary
- US HHS suggests updating testosterone therapy labels.
- New data shows no significant heart attack or stroke increase.
- Experts urge proper diagnosis and monitoring for therapy use.
The US Department of Health and Human Services has requested revisions to testosterone replacement therapy labels, prompted by a review of recent safety and benefit data. These proposed changes could potentially ease access to these treatments for men.
The agency aims to remove a statement indicating that the safety and effectiveness of testosterone therapy are not established for men with age-related low testosterone. Additionally, updates are suggested for information concerning prostate cancer risk and warnings about enlarged prostates.
While experts acknowledge that these revisions reflect evolving scientific understanding, they emphasize that testosterone therapy remains a medical treatment, not a wellness supplement. Proper diagnosis, thorough patient evaluations, and ongoing monitoring are crucial. The proposed label changes are intended to provide clearer information for informed medical decisions and improved patient care.
Recent large-scale studies involving over 5,200 men have found no significant increase in major cardiovascular events like heart attacks or strokes among those receiving testosterone therapy. Furthermore, newer research suggests that testosterone therapy does not generally increase the risk of prostate cancer, though its use may still be advised against for men with metastatic disease.
